Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD8 T-cell agon
Welcome,
Profile
Billing
Logout
31 Companies
32 Products
32 Products
91 Diseases
29 Trials
826 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
rhIL-15
/ National Cancer Institute
nemvaleukin alfa
(ALKS 4230) / Mural Oncology
VTP-300
/ Vaccitech
uzatresgene autoleucel
(ADP-A2M4CD8) / Adaptimmune, Galapagos
BAT6026
/ Bio-Thera Solutions
BNT111
/ BioNTech
HepTcell
(FP-02.2) / Altimmune
CD8+NKG2D+ AKT cell immunotherapy
/ iCELL Biotechnology
CN1
/ Curon Biopharma
Human tyrosinase DNA Vaccine
/ Ingro Finanz
IMA203CD8
/ Immatics
LB4330
/ L&L Biopharma
NEXI-001
/ NexImmune
8MW2311
/ Mabwell (Shanghai) Biosci
AB248
/ Asher Biotherap
AFNT-111
/ Affini-T Therap, Erasca
DF9001
/ Dragonfly Therap
EU103
/ Eutilex
EU204
/ Eutilex
FS222
/ Sino Biopharm
HFB200301
/ HiFiBiO
IL-12 engineered TIL
/ National Cancer Institute
IL-15 DC
/ Baylor University
JCXH-212
/ Immorna
NEXI-002
/ NexImmune
NEXI-003
/ NexImmune
NM32-2668
/ Numab
PDC*lung
/ PDC line Pharma
SLC-3010
/ Selecxine
SQZ-eAPC-HPV
/ STEMCELL Technologies
XmAb662
/ Xencor
